Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

FDA allows use of over-the-counter home test for COVID-19

A home test for COVID-19 will soon be on U.S. store shelves

Via AP news wire
Tuesday 15 December 2020 12:11 EST
Virus Outbreak Home Test
Virus Outbreak Home Test (Ellume)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

The first home test for COVID-19 that doesn't require a prescription will soon be on U.S. store shelves.

U.S. officials Tuesday authorized the rapid coronavirus test which can be done entirely at home. The announcement by the Food and Drug Administration represents another important — though incremental — step in U.S. efforts to expand testing options.

The agency's action allows the test to be sold in places like drugstores "where a patient can buy it, swab their nose, run the test and find out their results in as little as 20 minutes,” said FDA Commissioner Stephen Hahn, in a statement.

Regulators granted emergency use for a similar test last month, but that one requires a doctor’s prescription.

Initial supplies of the over-the-counter test will be limited. Australian manufacturer Ellume said it expects to produce 3 million tests next month before ramping up production over the first half of 2021.

A company spokesperson said the test will be priced around $30 and be available at pharmacies and online. The test connects to a digital app to help users interpret the results.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in